The DM-linked pathways identified (i.e., insulin resistance, adherens junctions, metabolic processes, and the IL-17, cAMP, relaxin, TNF, and AGE-RAGE signaling pathways involved in diabetic complications) were used to construct the target-pathway (TP) network. The gene discussed is IL17A; the disease is Insulin resistance.